XORTX Therapeutics (ANUA.F) Q3 2025 Earnings

14AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.46
-0.29
-0.12
0.05

Details

Expected EPS
-0.21459
Actual EPS
-0.1630884
Surprise EPS
0.05
Surprise Percent
+24%

Description

XORTX Therapeutics (ANUA.F) has reported earnings of -0.1630884 per share for Q3 2025.

0 Comments

Share your thoughts